Fig 4
Gabapentin Capsule
Product Images NDC 80425-0082
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2
This appears to be a table or graph with different treatments and their effects on pain scores. Not enough information is given to provide a comprehensive description, but it seems that there are two different dosing periods being evaluated. The treatments listed are placebo, Gatspntin at a dose of 1600y, and Gaagentn at a dose of 2400sy. The pain scores are listed across the top, starting with the baseline score, and the table seems to have been divided into different time points. Without more context or information, it is difficult to know precisely what this data represents, but it appears to be related to a pain management study of some kind.*
Figure 3
The text describes Figure 3 of Controlled PHN Studies showing the proportion of patients who saw more than 50% reduction in pain score at endpoint. The graph shows various studies with different dosages of drugs. The drugs shown are PBO, GBP 3600, GBP 1800, and GBP 2400. DBNull*
Figure
Gabapentin 400mg Tab Qty 90 Ndc 80425 0082
This is a description of a pharmaceutical product. The package contains 90 capsules of Gabapentin 400mg each, packed by a company called "Advanced".*
Structure
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
